Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2024-12-12 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2024
Regulatory Filings
2024-12-12 English
Confirmation of Implementation Timetable 2 pages 185.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 13 December 2024 regarding the confirmation of the implementation timetable for the Holdco IPO and related scheme events. It provides specific dates for trading commencement, IPO completion, and dispatch of share statements. The text explicitly states it is an announcement and does not contain financial statements or detailed financial analysis. It also references previous announcements and scheme booklets but does not itself present a report or detailed financial data. The document length is 4445 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it relates to the IPO and capital structure changes, specifically the implementation timetable of the Holdco IPO and scheme.
2024-12-12 English
ATGC Announces Pricing of US Initial Public Offering 2 pages 190.1KB
Capital/Financing Update Classification · 100% confidence The document is an ASX announcement dated 13 December 2024 regarding the pricing of Anteris Technologies Global Corp.'s U.S. Initial Public Offering (IPO). It details the number of shares offered, the offering price, expected trading start date on Nasdaq, use of proceeds, underwriters, and regulatory filing status with the SEC. The document is an announcement of a capital raising event (IPO pricing and details), not a financial report or earnings release. It does not contain financial statements or detailed financial analysis but focuses on the financing activity and capital structure changes. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length (7375 characters) and content confirm it is a full announcement, not just a brief notice or report publication announcement.
2024-12-12 English
OWNERSHIP DOCUMENT
Director's Dealing
2024-12-10 English
OWNERSHIP DOCUMENT
Director's Dealing
2024-12-10 English
OWNERSHIP DOCUMENT
Director's Dealing
2024-12-10 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.